Regulation of T‐cell immunity by leucocyte immunoglobulin‐like receptors: innate immune receptors for self on antigen‐presenting cells
暂无分享,去创建一个
[1] M. Colonna,et al. Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.
[2] S. Goerdt,et al. A gene signature of inhibitory MHC receptors identifies a BDCA3+ subset of IL‐10‐induced dendritic cells with reduced allostimulatory capacity in vitro , 2004, European journal of immunology.
[3] J. Dausset,et al. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6—STAT3 signaling pathway , 2008, Proceedings of the National Academy of Sciences.
[4] Michael J. Wilson,et al. Arrangement of the ILT gene cluster: a common null allele of the ILT6 gene results from a 6.7‐kbp deletion , 2000, European journal of immunology.
[5] R. Apps,et al. A critical look at HLA-G. , 2008, Trends in immunology.
[6] D. Mancini,et al. High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. , 2003, Transplant immunology.
[7] V. D’Agati,et al. Soluble Ig-Like Transcript 3 Inhibits Tumor Allograft Rejection in Humanized SCID Mice and T Cell Responses in Cancer Patients1 , 2007, The Journal of Immunology.
[8] Wei Zhang,et al. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. , 2007, Human immunology.
[9] M. Weller,et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. , 2005, Brain : a journal of neurology.
[10] J. Dausset,et al. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule , 2002, AIDS.
[11] H. Ljunggren,et al. Human cytomegalovirus‐derived protein UL18 alters the phenotype and function of monocyte‐derived dendritic cells , 2008, Journal of leukocyte biology.
[12] R. Dummer,et al. Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. , 2004, Blood.
[13] M. Bonneville,et al. Coordinated Expression of Ig-Like Inhibitory MHC Class I Receptors and Acquisition of Cytotoxic Function in Human CD8+ T Cells1 , 2004, Journal of Immunology.
[14] Wei Cao,et al. Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production , 2006 .
[15] Wei Zhang,et al. Human Inhibitory Receptor Immunoglobulin-Like Transcript 2 Amplifies CD11b+Gr1+ Myeloid-Derived Suppressor Cells That Promote Long-Term Survival of Allografts , 2008, Transplantation.
[16] Kouhei Tsumoto,et al. Efficient Leukocyte Ig-like Receptor Signaling and Crystal Structure of Disulfide-linked HLA-G Dimer* , 2006, Journal of Biological Chemistry.
[17] S. Kim-Schulze,et al. Recombinant Ig-Like Transcript 3-Fc Modulates T Cell Responses via Induction of Th Anergy and Differentiation of CD8+ T Suppressor Cells1 , 2006, The Journal of Immunology.
[18] J. S. Hunt,et al. Synthesis of β2‐microglobulin‐free, disulphide‐linked HLA‐G5 homodimers in human placental villous cytotrophoblast cells , 2007, Immunology.
[19] Wei Cao,et al. Plasmacytoid dendritic cell–specific receptor ILT7–FcɛRIγ inhibits Toll-like receptor–induced interferon production , 2006, The Journal of experimental medicine.
[20] R. Cortesini,et al. ILT3+ ILT4+ Tolerogenic Endothelial Cells in Transplantation , 2006, Transplantation.
[21] G. Aversa,et al. Interleukin 10 regulates cell surface and soluble LIR‐2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro , 2004, European journal of immunology.
[22] Wei Zhang,et al. Tolerization of dendritic cells by HLA‐G , 2005, European journal of immunology.
[23] M. Colonna,et al. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor‐β1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA‐I , 2007, Transfusion.
[24] P. Berloco,et al. Detection of T suppressor cells in patients with organ allografts. , 2001, Human immunology.
[25] Kouhei Tsumoto,et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] J. Arm. Generation of cytokines through the leucocyte immunoglobulin‐like receptors , 2004 .
[27] T. Bellón,et al. Amoxicillin conjugates to HLA class I molecules and interferes with signalling through the ILT2/LIR‐1/CD85j inhibitory receptor , 2007, Allergy.
[28] D. Scott‐Algara,et al. The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells , 2008, PloS one.
[29] N. Rouas-Freiss,et al. Evidence to Support the Role of HLA-G5 in Allograft Acceptance through Induction of Immunosuppressive/ Regulatory T Cells1 , 2006, The Journal of Immunology.
[30] G. Leclercq,et al. Interactions of Ly49 Family Receptors with MHC Class I Ligands in trans and cis1 , 2007, The Journal of Immunology.
[31] D. Mancini,et al. Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. , 2004, International immunology.
[32] M. Colonna,et al. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways , 1997, European journal of immunology.
[33] M. Derrien,et al. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. , 2004, Human immunology.
[34] S. Agrawal,et al. The role of human leukocyte antigen E and G in HIV infection. , 2007, AIDS.
[35] Todd M. Allen,et al. A viral CTL escape mutation leading to immunoglobulin-like transcript 4–mediated functional inhibition of myelomonocytic cells , 2007, The Journal of experimental medicine.
[36] R. Cortesini,et al. Central role of ILT3 in the T suppressor cell cascade. , 2007, Cellular immunology.
[37] P. Vermersch,et al. Association of multiple sclerosis with ILT6 deficiency , 2005, Genes and Immunity.
[38] R. González-Amaro,et al. Analysis of expression and function of the inhibitory receptor ILT2 (CD85j/LILRB1/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). , 2007, Journal of autoimmunity.
[39] M. Kubin,et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.
[40] S. Kim-Schulze,et al. Role of regulatory and suppressor T-cells in the induction of ILT3+ ILT4+ tolerogenic endothelial cells in organ allografts. , 2004, Transplant immunology.
[41] J. Strominger,et al. Disulfide bond-mediated dimerization of HLA-G on the cell surface , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[42] F. Mulcahy,et al. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function. , 2007, Clinical immunology.
[43] Kouhei Tsumoto,et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d) , 2006, Proceedings of the National Academy of Sciences.
[44] Masahiro Yamamura,et al. Use of Genetic Profiling in Leprosy to Discriminate Clinical Forms of the Disease , 2003, Science.
[45] V. Guiard,et al. © 1999 The Japanese Society for Immunology IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes , 2022 .
[46] Philippe Moreau,et al. HLA-G: from biology to clinical benefits. , 2008, Trends in immunology.
[47] E. Carosella,et al. HLA‐G up‐regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] G. Cheng,et al. LILRA2 Activation Inhibits Dendritic Cell Differentiation and Antigen Presentation to T Cells1 , 2007, The Journal of Immunology.
[49] G. Screaton,et al. Ig-Like Transcript 4 Inhibits Lipid Antigen Presentation through Direct CD1d Interaction1 , 2009, The Journal of Immunology.
[50] J. Dausset,et al. HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Trowsdale,et al. The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells. , 2008, Blood.
[52] G. Trinchieri,et al. CD85j (Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2) Inhibits Human Osteoclast-Associated Receptor-Mediated Activation of Human Dendritic Cells1 , 2005, The Journal of Immunology.
[53] M. Colonna,et al. Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. , 1999, Journal of immunology.
[54] V. D’Agati,et al. Immunoglobulin-Like Transcript 3-Fc Suppresses T-Cell Responses to Allogeneic Human Islet Transplants in hu-NOD/SCID Mice , 2008, Diabetes.
[55] N. Rouas-Freiss,et al. NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G , 2008, Leukemia.
[56] M. Kubin,et al. LIR9, an immunoglobulin-superfamily-activating receptor, is expressed as a transmembrane and as a secreted molecule. , 2003, Blood.
[57] A. Nakamura,et al. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation , 2007, The Journal of experimental medicine.
[58] C. Reis e Sousa,et al. Toll-like receptors and dendritic cells: for whom the bug tolls. , 2004, Seminars in immunology.
[59] N. Rouas-Freiss,et al. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. , 2008, Blood.
[60] N. Rouas-Freiss,et al. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways. , 2007, Human immunology.
[61] A. McMichael,et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. , 2002, Arthritis and rheumatism.
[62] M. Zenke,et al. Immunoglobulin-like transcripts ILT2, ILT3 and ILT7 are expressed by human dendritic cells and down-regulated following activation. , 2004, Gene.
[63] C. Gleissner,et al. IL‐10 inhibits endothelium‐dependent T cell costimulation by up‐regulation of ILT3/4 in human vascular endothelial cells , 2007, European journal of immunology.
[64] S. Beck,et al. Plasticity in the organization and sequences of human KIR/ILT gene families. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[65] D. Cosman,et al. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[66] U. Švajger,et al. Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4. , 2008, International immunopharmacology.
[67] Michael J. Wilson,et al. Killer Cell Ig-Like Receptor and Leukocyte Ig-Like Receptor Transgenic Mice Exhibit Tissue- and Cell-Specific Transgene Expression 1 , 2003, The Journal of Immunology.
[68] G. Vlad,et al. Regulatory CD8+CD28- T cells in heart transplant recipients. , 2003, Human immunology.
[69] G. Bhagat,et al. Expression of inhibitory receptor ILT3 on neoplastic B cells is associated with lymphoid tissue involvement in chronic lymphocytic leukemia , 2007, Cytometry. Part B, Clinical cytometry.
[70] Giuseppe Penna,et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. , 2005, Blood.
[71] N. Rouas-Freiss,et al. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. , 2007, Seminars in cancer biology.
[72] P. Bjorkman,et al. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor , 2003, Nature Immunology.
[73] B. Mordmüller,et al. Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria. , 2006, European cytokine network.
[74] D. Jarrossay,et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.
[75] K. Austen,et al. Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. , 2004, Blood.
[76] M. Colonna,et al. Cutting Edge: Human Myeloid Cells Express an Activating ILT Receptor (ILT1) That Associates with Fc Receptor γ-Chain , 1999, The Journal of Immunology.
[77] P. Parham,et al. Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex , 2001, Immunogenetics.
[78] A. McMichael,et al. Expression of leukocyte immunoglobulin-like receptors and natural killer receptors on virus-specific CD8+ T cells during the evolution of Epstein-Barr virus-specific immune responses in vivo. , 2005, Viral immunology.
[79] J. S. Hunt,et al. Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords. , 2008, Placenta.
[80] E. Carosella,et al. Soluble HLA‐G Expression and Renal Graft Acceptance , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[81] R. Lechler,et al. Aspirin‐Treated Human DCs Up‐Regulate ILT‐3 and Induce Hyporesponsiveness and Regulatory Activity in Responder T Cells , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[82] F. Gros,et al. Elevated levels of soluble non‐classical major histocompatibility class I molecule human leucocyte antigen (HLA)‐G in the blood of HIV‐infected patients with or without visceral leishmaniasis , 2006, Clinical and experimental immunology.
[83] S. Kim-Schulze,et al. Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review. , 2005, International immunopharmacology.
[84] P. Gao,et al. Expression of Ig-like transcript 4 inhibitory receptor in human non-small cell lung cancer. , 2008, Chest.
[85] K. Arai,et al. SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production. , 2008, International immunology.
[86] A. Makrigiannis,et al. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC , 2008, The Journal of experimental medicine.
[87] M. Claesson,et al. Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3). , 2004, Immunology letters.
[88] L. O’Neill. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. , 2008, Immunity.
[89] R. González-Amaro,et al. Phenotypic Analysis of IL‐10‐treated, Monocyte‐derived Dendritic Cells in Patients with Systemic Lupus Erythematosus , 2006, Scandinavian journal of immunology.
[90] W. Heath,et al. Immunity or tolerance? That is the question for dendritic cells , 2001, Nature Immunology.
[91] J. Lieberman,et al. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen‐specific effector CD8 T cells and its impact on CD8 T‐cell function , 2004, Immunology.
[92] S. Olofsson,et al. LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients , 2003, The Lancet.
[93] Michael J. Wilson,et al. Cutting Edge: Leukocyte Receptor Complex-Encoded Immunomodulatory Receptors Show Differing Specificity for Alternative HLA-B27 Structures1 , 2001, The Journal of Immunology.
[94] C. Geczy,et al. Down-regulation of leucocyte immunoglobulin-like receptor expression in the synovium of rheumatoid arthritis patients after treatment with disease-modifying anti-rheumatic drugs. , 2007, Rheumatology.
[95] R. Schmidt,et al. Immunoglobulin‐like Transcripts as Risk Genes for Autoimmunity , 2007, Annals of the New York Academy of Sciences.
[96] M. Claesson,et al. Induction of regulatory dendritic cells by dexamethasone and 1α,25-Dihydroxyvitamin D3 , 2004 .
[97] G. Vlad,et al. Interleukin-10 induces the upregulation of the inhibitory receptor ILT4 in monocytes from HIV positive individuals. , 2003, Human immunology.